A detailed history of John G Ullman & Associates Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, John G Ullman & Associates Inc holds 7,435 shares of UTHR stock, worth $2.7 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
7,435
Previous 7,450 0.2%
Holding current value
$2.7 Million
Previous $2.37 Million 12.26%
% of portfolio
0.41%
Previous 0.38%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$311.04 - $363.55 $2.31 Million - $2.7 Million
7,435 New
7,435 $2.66 Million
Q2 2024

Aug 08, 2024

SELL
$228.26 - $319.04 $68,478 - $95,712
-300 Reduced 3.87%
7,450 $2.37 Million
Q1 2024

May 06, 2024

SELL
$210.76 - $249.51 $290,848 - $344,323
-1,380 Reduced 15.12%
7,750 $1.78 Million
Q4 2023

Jan 31, 2024

SELL
$214.88 - $256.94 $21,488 - $25,694
-100 Reduced 1.08%
9,130 $2.01 Million
Q3 2023

Nov 01, 2023

SELL
$211.82 - $248.24 $26,477 - $31,030
-125 Reduced 1.34%
9,230 $2.08 Million
Q2 2023

Aug 21, 2023

BUY
$205.19 - $232.99 $190,826 - $216,680
930 Added 11.04%
9,355 $2.07 Million
Q1 2023

May 05, 2023

BUY
$212.99 - $276.17 $1.79 Million - $2.33 Million
8,425 New
8,425 $1.89 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track John G Ullman & Associates Inc Portfolio

Follow John G Ullman & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of John G Ullman & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on John G Ullman & Associates Inc with notifications on news.